SEC Form 4 · accession 0001225208-15-021324
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert W.A. Sellers
Officer — VP, Corporate Controller
Period of report
Nov 23, 2015
Accepted (ET)
Nov 23, 2015 · 7:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 23, 2015 | M | 4,800 | $31.47 | A | 17,958 | D | |
| Common StockF1 | Nov 23, 2015 | S | 4,800 | $157.13 | D | 13,158 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Acquire) | $31.47 | Nov 23, 2015 | M | 4,800 | D | May 7, 2010 | May 6, 2016 | Common Stock | 4,800 | 0 | D |
Explanation of responses
- F1This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.